HKU Scholars Hub: Browsing DSpace

Browsing by Author rp01466

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 24 to 43 of 297 < previous next >

Title	Author(s)	Issue Date
Bevacizumab-based therapy for advanced small bowel adenocarcinoma Journal:Gut	Tsang, H Yau, T Khong, PL Epstein, RJ	2008
Biological Therapy in Hepatocellular Carcinoma Proceeding/Conference:Chinese Society of Hepatology Annual Meeting, Beijing, China	Yau, TCC	2016
Breast and pelvic masses in a myeloma patient Journal:Annals of Hematology	Hwang, YY Chim, CS Chan, G Loong, F Yau, T	2008
Cabozantinib in combination with atezolizumab versus sorafenib in treatment-naive advanced hepatocellular carcinoma: COSMIC-312 Phase III study design Journal:Future Oncology	Kelley, RK Oliver, JW Hazra, S Benzaghou, Fawzi Yau, T Cheng, AL Rimassa, L	2020
Cancer Immunotherapy: Recent Advances and Impact on Survival Proceeding/Conference:1st HKU International Musculoskeletal Tumour Course, Hong Kong	Yau, TCC	2017
Case 2. Mantle-cell lymphoma of the prostate gland Journal:Journal of Clinical Oncology	Chim, CS Loong, F Yau, T Ooi, GC Liang, R	2003
A case of mixed adult Wilms' tumour and angiosarcoma responsive to carboplatin, etoposide and vincristine (CEO) Journal:Cancer Chemotherapy and Pharmacology	Yau, T Leong, CH Chan, WK Chan, JK Liang, RHS Epstein, RJ	2008
CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma Journal:Proceedings of the National Academy of Sciences	Chan, Cerise Yuen-Ki Chiu, David Kung-Chun Yuen, Vincent Wai-Hin Law, Cheuk-Ting Wong, Bowie Po-Yee Thu, Kelsie Lynn Cescon, David Ward Soria-Bretones, Isabel Cheu, Jacinth Wing-Sum Lee, Derek Tse, Aki Pui-Wah Zhang, Misty Shuo Tan, Kel Vin Ng, Irene Oi-Lin Khong, Pek-Lan Yau, Thomas Chung-Cheung Bray, Mark Robert Mak, Tak Wah Wong, Carmen Chak-Lui	1-Aug-2022
Challenges in the Management of Advanced Hepatocellular carcinoma in the Era of Precision Medicine and Immunotherapy Proceeding/Conference:Chinese Society of Hepatology Annual Meeting, Beijing, China	Yau, TCC	2016
Changing pattern of recurrences in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy in the era of dual anti-HER2 therapy Journal:Postgraduate Medical Journal	Chiu, JW Leung, R Tang, V Cheuk, WY Lo, J Kwok, GW Wong, H Suen, D Cheung, P Wong, TT Yau, T Kwong, A	2019
Checkpoint Inhibitors and Tyrosine Inhibitors Post Immunotherapy in the Management of Advanced HCC Proceeding/Conference:Ipsen Hepatocellular carcinoma (HCC) Asia Scientific Meeting, Seoul, South Korea	Yau, TCC	2019
Checkpoint Inhibitors: Taking Off the Brakes in Immune System Proceeding/Conference:State key Laboratory for Liver Research Symposium 2017, Li Ka Shing Faculty of Medicine, The University of Hong Kong	Yau, TCC	2017
Chemotherapy and Adjuvant Chemotherapy for Colorectal Cancer Proceeding/Conference:Symposium on Updates on Management of Colorectal Cancer	Yau, TCC	2017
Circulating oncometabolite 2-hydroxyglutarate (2HG) as a potential surrogate biomarker in patients with isocitrate dehydrogenase mutant (IDHm) intrahepatic cholangiocarcinoma (ICC) Proceeding/Conference:Journal of Clinical Oncology	Goyal, L Borger, DR Yau, T Poon, RTP Ancukiewicz, M Christiani, DC Liebman, HM Yen, K Straley, K Agresta, SV Faris, JE Kwak, EL Clark, JW Ryan, DP Tanabe, K Deshpande, V Jain, RK Iafrate, AJ Duda, DG Zhu, AX	2013
Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma Journal:Clinical Cancer Research	Borger, DR Goyal, L Yau, TCC Poon, RTP Ancukiewicz, M	2014
Clinical and immunologic responses to a B-cell epitope vaccine in patients with HER2/neu-overexpressing advanced gastric cancer—Results from phase Ib trial IMU.ACS.001 Journal:Clinical Cancer Research	Wiedermann, U Garner-Spitzer, E Chao, Y Maglakelidze, M Bulat, I Dechaphunkul, A Arpornwirat, W Charoentum, C Yen, CJ Yau, TC Tanasanvimon, S Maneechavakajorn, J Sookprasert, A Bai, LY Chou, WC Ungtrakul, T Drinic, M Tobias, J Zielinski, CC Chong, L Ede, NJ Marino, MT Good, AJ	2021
The clinicopathological significance of miR-133a in colorectal cancer Journal:Disease Markers	Wan, TMH Lam, CSC Ng, L Chow, KM Wong, SKM Li, HS Man, HW Lo, OSH Foo, CC Cheung, A Yau, TCC Poon, TCJ Poon, RTP Law, WL Pang, RWC	2014
Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine Journal:PLoS Medicine	Goh, G Schmid, R Guiver, K Arpornwirat, W Chitapanarux, I Ganju, V Im, SA Kim, SB Dechaphunkul, A Maneechavakajorn, J Spector, N Yau, TCC Afrit, M Ben Ahmed, S Johnston, SR Gibson, N Uttenreuther-Fischer, M Swanton, C	2016
Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer Journal:Medical Oncology	Wong, H Lau, S Leung, R Chiu, J Cheung, P Wong, TT Liang, R Epstein, RJ Yau, T	2012
Colon cancer in a patient with underlying aplastic anemia: A clinical challenge Journal:World Journal of Clinical Oncology	Wong, H Chan, P Yau, TCC	2012

Showing results 24 to 43 of 297 < previous next >